Phenylketonuria Treatment Market – Industry, Growth, Trends, Outlook, and Analysis, 2018-2026

1. Phenylketonuria Treatment Market - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026 © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Phenylketonuria Treatment Market – Overview Frequent research for development of novel drugs for the treatment of phenylketonuria is expected to drive growth of global phenylketonuria treatment market in the near future. For instance, in 2017, BioMarin Pharmaceutical Inc. submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its new Pegvaliase, indicated for the treatment of patients with Phenylketonuria (PKU). In 2018, European Medicines Agency (EMA) accepted BioMarin’s submission of a Marketing Authorization Application (MAA) for pegvaliase for the treatment of adults with phenylketonuria (PKU) who have inadequate blood phenylalanine control (blood phenylalanine levels greater than 600 micromol/l). In 2017, Synlogic, Inc. received Orphan Drug Designation for its SYNB1618 from U.S. Food and Drug Administration. SYNB1618, an orally administered synthetic biotic medicine indicated for the treatment of PKU. Furthermore, increasing acquisitions and collaborations between key players is also expected to create a lucrative environment for growth of global phenylketonuria treatment market. Phenylketonuria (PKU) is a rare genetic disorder caused due to increased level of phenylalanine in the blood. The excess amount of phenylalanine can cause intellectual disability and other serious health problems. The most severe condition of this disorder is termed as classic PKU and symptoms related to it are seizures, tremors, or trembling and shaking, stunted growth, hyperactivity, skin conditions such as eczema, and musty odor of their breath, skin, or urine. PKU can be managed by maintaining phenylalanine free diet. © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Phenylketonuria Treatment Market Taxonomy: Phenylketonuria Treatment Market Taxonomy: By Treatment Type: By Treatment Type: Drugs Drugs ● ● Kuvan Kuvan ● ● Pegvaliase Pegvaliase ● ● Others Others ● ● Dietary Supplement Dietary Supplement ● ● By Route of Administration: By Route of Administration: Oral Oral ● ● Parenteral Parenteral ● ● Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1648 Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1648 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Bio-absorbable Bone Screw Market: Key Players BioMarin Pharmaceutical Inc. ● Dimension Therapeutics, Inc. ● American Gene Technologies International Inc. ● Synthetic Biologics, Inc. ● Codexis, Inc. ● SOM Innovation Biotech SL. ● Daiichi Sankyo Company. ● Limited, and Erytech Pharma SA. ● View this report @ https://www.coherentmarketinsights.com/ongoing-insight/phenylketonuria-treatment-market-1648 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT COHERENT MARKET INSIGHTS SECTOR COVERAGE Healthcare CLINICAL DIAGNOSTIC HEALTHCARE IT PHARMACEUTICAL MEDICAL IMAGING MEDICAL DEVICES Chemicals & Materials Speciality and Fine Chemicals Advanced Materials Bulk Chemicals Green Chemicals Polymers & Resins Food Ingredients Cosmetic Ingredients © Coherent market Insights. All Rights Reserved

7. ABOUT COHERENT MARKET INSIGHTS KEY STATS RESEARCH SOLUTIONS GLOBAL REPORTS FEASIBILITY STUDIES 100+ Insights Published Per Year CUSTOMIZED SOLUTIONS COUNTRY ANALYSIS 150+ CONSULT PROJECTS Consulting Projects Till Date SURVEY RESEARC H EXCEL FORECAST DATABASE 125+ COMPETITIVE ASSESSMENT Clients Worldwide Per Year 110+ TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. T o know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentm arketinsights.com THANK YOU For other queries contact: Mr. Shah (M anager - Business Development) C oherent Market Insights sales@coherentm arketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved